BioCrude Technologies USA, Inc. Quarterly Operating Income (Loss) in USD from Q2 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioCrude Technologies USA, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2016 to Q2 2024.
  • BioCrude Technologies USA, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$63.6K, a 32.2% increase year-over-year.
  • BioCrude Technologies USA, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$271K, a 2.31% decline year-over-year.
  • BioCrude Technologies USA, Inc. annual Operating Income (Loss) for 2023 was -$240K, a 35.3% decline from 2022.
  • BioCrude Technologies USA, Inc. annual Operating Income (Loss) for 2022 was -$178K, a 58.4% increase from 2021.
  • BioCrude Technologies USA, Inc. annual Operating Income (Loss) for 2021 was -$427K, a 50.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$271K -$63.6K +$30.2K +32.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$302K -$123K -$61.1K -99.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$240K -$36.8K -$15.1K -69.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$225K -$48.4K +$39.9K +45.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$265K -$93.8K -$79.2K -545% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$186K -$61.5K -$8.41K -15.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$178K -$21.8K +$44.8K +67.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$222K -$88.3K -$42.4K -92.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$180K -$14.5K +$138K +90.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$318K -$53K +$110K +67.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$427K -$66.6K +$115K +63.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$543K -$45.9K +$13.6K +22.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$556K -$152K -$130K -593% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$426K -$163K -$142K -696% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$284K -$182K -$63.7K -53.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$220K -$59.5K -$4.74K -8.66% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$215K -$22K +$25.1K +53.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 -$240K -$20.4K +$33.9K +62.4% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-12
Q4 2019 -$274K -$118K -$140K -647% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-12
Q3 2019 -$135K -$54.8K +$3.03K +5.24% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$138K -$47.1K -$20.2K -75.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$117K -$54.3K +$691K +92.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$809K $21.6K +$219K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$1.03M -$57.8K +$165K +74% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$1.19M -$26.9K +$566 +2.06% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$1.19M -$745K -$695K -1377% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$498K -$197K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-17
Q3 2017 -$222K -$183K -459% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$27.4K +$28.9K +51.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-24
Q1 2017 -$50.5K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-16
Q3 2016 -$39.8K Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 -$56.3K Apr 1, 2016 Jun 30, 2016 10-Q 2017-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.